157 related articles for article (PubMed ID: 28184030)
1. Genetic variants in RhoA and ROCK1 genes are associated with the development, progression and prognosis of prostate cancer.
Liu K; Li X; Wang J; Wang Y; Dong H; Li J
Oncotarget; 2017 Mar; 8(12):19298-19309. PubMed ID: 28184030
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
5. Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer.
Reis ST; Viana NI; Leite KR; Diogenes E; Antunes AA; Iscaife A; Nesrallah AJ; Passerotti CC; Srougi V; Pontes-Junior J; Salles ME; Nahas WC; Srougi M
PLoS One; 2016; 11(12):e0166380. PubMed ID: 27906997
[TBL] [Abstract][Full Text] [Related]
6. Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.
Hunter SM; Rowley SM; Clouston D; ; Li J; Lupat R; Krishnananthan N; Risbridger G; Taylor R; Bolton D; Campbell IG; Thorne H
Urol Oncol; 2016 Mar; 34(3):120.e9-16. PubMed ID: 26585945
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
[TBL] [Abstract][Full Text] [Related]
9. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer.
Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Juang SH; Bao BY
Sci Rep; 2015 Feb; 5():8556. PubMed ID: 25707771
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer risk variants are not associated with disease progression.
Szulkin R; Holmberg E; Stattin P; Xu J; Zheng S; Palmgren J; Grönberg H; Wiklund F
Prostate; 2012 Jan; 72(1):30-9. PubMed ID: 21520160
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer.
Huang CY; Huang SP; Lin VC; Yu CC; Chang TY; Lu TL; Chiang HC; Bao BY
Sci Rep; 2015 Sep; 5():14045. PubMed ID: 26365175
[TBL] [Abstract][Full Text] [Related]
14. The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance.
Wang W; Yuasa T; Tsuchiya N; Ma Z; Maita S; Narita S; Kumazawa T; Inoue T; Tsuruta H; Horikawa Y; Saito M; Hu W; Ogawa O; Habuchi T
Int J Cancer; 2009 Dec; 125(12):2836-43. PubMed ID: 19585577
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A
Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Chen QB; Liang YK; Zhang YQ; Jiang MY; Han ZD; Liang YX; Wan YP; Yin J; He HC; Zhong WD
Tumour Biol; 2017 Jun; 39(6):1010428317703924. PubMed ID: 28651494
[TBL] [Abstract][Full Text] [Related]
17. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
Johnson IR; Parkinson-Lawrence EJ; Keegan H; Spillane CD; Barry-O'Crowley J; Watson WR; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
Oncotarget; 2015 Nov; 6(35):37919-29. PubMed ID: 26473288
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.
Pehlivan Y; Yolbas S; Cetin GY; Alibaz-Oner F; Cagatay Y; Yilmaz N; Oztuzcu S; Donmez S; Ozgen M; Koca SS; Pamuk ON; Sayarlıoglu M; Kisacik B; Direskeneli H; Demiryurek AT; Onat AM
Rheumatol Int; 2016 Mar; 36(3):421-7. PubMed ID: 26615410
[TBL] [Abstract][Full Text] [Related]
19. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.
Lee CH; Pao JB; Lu TL; Lee HZ; Lee YC; Liu CC; Huang CY; Lin VC; Yu CC; Yin HL; Huang SP; Bao BY
Int J Med Sci; 2016; 13(9):696-700. PubMed ID: 27647999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
